Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma
About this PQI
The purpose of this PQI is to understand the management techniques and interventions related to the utilization of the combination treatment of enfortumab vedotin-ejfv and pembrolizumab.
More About This PQI
PQI:
PQI in Action Articles:
PQI in Action Articles:
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol
Author: Sharon Zhong, PharmD, BCOP
Last Updated: 08/14/2025
PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC
Author: Aubrey Lasko, PharmD, BCOP
Last Updated: 08/14/2025
PQI: Bone Health and the Cancer Patient
Author: Nina DiPierro Pharm.D. BCOP, Florida Cancer Specialists and Research Institute | Farishta Manzoor, PharmD, Hartford HealthCare Cancer Institute
Last Updated: 08/14/2025
PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer
Author: Jennah Bauernfeind, PharmD, BCOP
Last Updated: 08/14/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 08/14/2025
PQI in Action: Proactive Symptom Management in Myelofibrosis
Author: Cancer Specialists of North Florida
Last Updated: 08/14/2025
PQI in Action: Sonidegib (Odomzo®) Patient Management
Author: UCLA Medical Center | The Ohio State University Cancer Comprehensive Cancer Center (The James) | WVU Medicine
Last Updated: 08/14/2025
PQI in Action: Larotrectinib (Vitrakvi®) Overview
Author: Upstate Cancer Center/Upstate Golisano Children’s Hospital, NY | Wolfson Children’s Hospital, FL
Last Updated: 08/14/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S8 Bonus Eps 2: Inside ASCO 2025
Author: Ginger Blackmon, PharmD | Kelly Brunk, PharmD, BCOP
Last Updated: 08/14/2025
S8 E15: Supporting Survivors at Work
Author: Ginger Blackmon, PharmD | Rebecca Nellis, MPP
Last Updated: 08/14/2025
S8 E14: Advancing Geriatric Oncology
Author: Ginger Blackmon, PharmD | William Dale, MD, PhD, FASCO
Last Updated: 08/14/2025
S8 Ep 13: Supporting Patients Through Financial Assistance
Author: Ginger Blackmon, PharmD | Michael Heimall, FACHE
Last Updated: 08/14/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Mirdametinib
Last Updated: 08/14/2025
Treatment Support Kit: Abemaciclib
Last Updated: 08/14/2025
Treatment Support Kit: Temozolomide
Last Updated: 08/14/2025
Treatment Support Kit: Tivozanib
Last Updated: 08/14/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 08/14/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 08/14/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 08/14/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 08/14/2025
PQI Podcast
PQI
PQI in Action
PQI in Action
PQI Podcast S6 Ep 7: Urology Clinic Best Practices
Author: Ginger Blackmon, PharmD | Melanie Boren MHA, RN, BSN, OCN | Robin Carr
Last Updated: 08/14/2025
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 08/14/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 08/14/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Seattle Cancer Care Alliance, WA | Georgia Cancer Specialists, GA
Last Updated: 08/14/2025
PQI
PQI in Action
PQI in Action
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 08/14/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 08/14/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Seattle Cancer Care Alliance, WA | Georgia Cancer Specialists, GA
Last Updated: 08/14/2025
PQI Podcast
PQI
The PQI Podcast S4 Ep 20: Cancer Immunotherapy
Author: Ginger Blackmon, PharmD | Mary Elizabeth Williams
Last Updated: 08/14/2025
PQI: Axitinib (Inlyta®) Plus Pembrolizumab (Keytruda®) for Advanced Renal Cell Carcinoma
Author: Jennifer Craig, PharmD, CSP | Amber Rollo, PharmD, CSP, AAHIVP
Last Updated: 08/14/2025
PQI
PQI in Action
PQI in Action
PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Andrew Ruplin, PharmD
Last Updated: 08/14/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2
Author: City of Hope, IL | City of Hope, GA | Baptist MD Anderson Cancer Center, FL
Last Updated: 08/14/2025
PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma
Author: Seattle Cancer Care Alliance, WA | Georgia Cancer Specialists, GA
Last Updated: 08/14/2025
PQI Podcast
PQI
The PQI Podcast S4 Ep 20: Cancer Immunotherapy
Author: Ginger Blackmon, PharmD | Mary Elizabeth Williams
Last Updated: 08/14/2025
PQI: Axitinib (Inlyta®) Plus Pembrolizumab (Keytruda®) for Advanced Renal Cell Carcinoma
Author: Jennifer Craig, PharmD, CSP | Amber Rollo, PharmD, CSP, AAHIVP
Last Updated: 08/14/2025
PQI
PQI
PQI in Action
PQI
PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol
Author: Sharon Zhong, PharmD, BCOP
Last Updated: 08/14/2025
PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC
Author: Aubrey Lasko, PharmD, BCOP
Last Updated: 08/14/2025
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 08/14/2025
PQI: Bone Health and the Cancer Patient
Author: Nina DiPierro Pharm.D. BCOP, Florida Cancer Specialists and Research Institute | Farishta Manzoor, PharmD, Hartford HealthCare Cancer Institute
Last Updated: 08/14/2025